ea0029p1408 | Pituitary Clinical | ICEECE2012
Webb S
, Badia X
, Zgliczynski W
, Portocarrero-Ortiz L
, Maldonado M
, Trovato A
, Forsythe A
, Nelson L
, McLeod L
, De Block C
, Gadelha M
Introduction: Patients with Cushings disease have significantly impaired health-related quality of life (HRQoL). Effective treatment is needed to treat Cushings disease and improve HRQoL; however, there are currently no approved medical treatments for Cushings disease. The effect of pasireotide on HRQoL in patients with Cushings disease was evaluated as part of a randomized, phase III study.Methods: Patients with persistent/recurr...